Valor do ácido hialurônico na hepatite crônica C

Lima, Leila Maria Soares Tojal de Barros; Martins, João Roberto Maciel; Lacet, Celina Maria Costa; Teixeira, Maria do Carmo Borges; Lopes, Antônio Carlos.
Rev. Soc. Bras. Clín. Méd ; 4(6): 189-195, 2006.
Artigo Português | LILACS | ID: lil-698622

Documentos relacionados

  1. Peri-complication diagnosis of hepatitis C infection: Risk factors and trends over time.
  2. Hepatitis C mortality trends in Mexico from 2001 to 2017.
  3. Adapted time-varying covariates Cox model for predicting future cirrhosis development performs well in a large hepatitis C cohort.
  4. Implementation of a re-linkage to care strategy in patients with chronic hepatitis C who were lost to follow-up in Latin America.
  5. Influence of chronic hepatitis C infection on the monocyte-to-platelet ratio: data analysis from the National Health and Nutrition Examination Survey (2009-2016).
  6. Impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection.
  7. Changes in the Distribution Pattern of Hepatitis C Virus Genotypes Among Chronic Hepatitis Patients: a Cross-Sectional Study.
  8. Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study.
  9. Addressing Hepatitis C in the American Incarcerated Population: Strategies for Nationwide Elimination.
  10. Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions by 2025.